What is the translation of " ML SOLUTION " in Croatian?

• ml otopina
• ml otopine
• ml otopini
• ml otopinu

Examples of using Ml solution in English and their translations into Croatian

Each pre-filled syringe contains 0.6 ml solution.
Jedna napunjena štrcaljkasadrži 0, 6 ml otopine.

Pre-filled pens of 0.5 ml solution 4 pre-filled pens of 0.5 ml solution.
Napunjene brizgalice s 0, 5 ml otopine 4 napunjene brizgalice s 0, 5 ml otopine.

Multi-pack: 4 pre-filled pens of 0.5 ml solution.
Višestruko pakiranje: 4 napunjene brizgalice s 0, 5 ml otopine.

Pre-filled pen of 1 ml solution 2 pre-filled pens of 1 ml solution 3 pre-filled pens of 1 ml solution.
Napunjena brizgalica s 1 ml otopine 2 napunjene brizgalice s 1 ml otopine 3 napunjene brizgalice s 1 ml otopine.

The active substance is ganirelix 0.25 mg in 0.5 mL solution.
Djelatna tvar je ganireliks 0, 25 mg u 0, 5 ml otopine.

Zoledronic acid medac 4 mg/100 ml solution for infusion should be given as a single intravenous infusion in no less than 15 minutes.
Zoledronatnu kiselinu medac 4 mg/100 ml otopinu za infuziju treba dati kao jednokratnu intravensku infuziju u trajanju od najmanje 15 minuta.

Do not freeze Humalog 200 units/ml solution for injection.
Ne zamrzavajte Humalog 200 jedinica/ml otopinu za injekciju.

NeoRecormon 500 IU, 2000 IU, 3000 IU, 4000 IU, 5000 IU and 6000 IU: Each pre-filled syringe contains 0.3 ml solution.
NeoRecormon 500 IU, 2000 IU, 3000 IU, 4000 IU, 5000 IU i 6000 IU: Svaka napunjena štrcaljka sadrži 0, 3 ml otopine.

Each vial of Atosiban SUN 6.75 mg/0.9 ml solution for injection contains atosiban acetate equivalent to 6.75 mg of atosiban in 0.9 ml..
Jedna bočica Atosiban SUN-a 6, 75 mg/0, 9 ml otopine za injekciju sadrži atosibanacetat što odgovara 6, 75 mg atosibana u 0, 9 ml..

Each pre-filled pen contains 150 mg alirocumab in 1 ml solution 150 mg/ml.
Jedna napunjena brizgalica sadrži 150 mg alirokumaba u 1 ml otopine 150 mg/ml.

After reconstitution with water for injection, 1.0 ml solution(0.9 mg thyrotropin alfa) is administered by intramuscular injection to the buttock.
Nakon rekonstitucije s vodom za injekcije, 1, 0 ml otopine(0, 9 mg tireotropina alfa) primjenjuje se intramuskularnom injekcijom u mišić stražnjice.

Alternatively therapy may be initiated with Loxicom 5 mg/ml solution for injection.
Alternativno, terapiju je moguće započeti Loxicom 5 mg/ml otopinom za injekciju.

Zoledronic acid medac 4 mg/100 ml solution for infusion can be used immediately without further preparation for patients with normal renal function.
Zoledronatna kiselina medac 4 mg/100 ml otopina za infuziju može se odmah primijeniti bez dodatne pripreme kod bolesnika s normalnom funkcijom bubrega.

Alternatively therapy may be initiated with Metacam 5 mg/ml solution for injection.
Kao druga mogućnost, može se započeti terapiju Metacamom 5 mg/ml otopinom za injekcije.

Zoledronic Acid Hospira 4 mg/100 ml solution for infusion can be used immediately without further preparation for patients with normal renal function.
Zolendrotana kiseline Hospira 4mg/100ml otopina za infuziju može se upotrijebiti odmah bez dodatne pripreme za bolesnike s normalnom funkcijom bubrega.

Use of Active Ultrasafe Needle Guard for Nivestim 12 MU/ 0.2 ml solution for injection/ infusion.
Uporaba aktivnog ultrasigurnog štitnika igle za Nivestim 12 MU/ 0, 2 ml otopini za injekciju/ infuziju.

Ml, 50 ml, 100 ml, 200 ml or 400 ml solution in a vial(type II glass) with stopper chloro-butyl- rubber.
Ml, 50 ml, 100 ml, 200 ml ili 400 ml otopina u staklenoj bočici(staklo tip II) s gumenim čepom klorobutil guma.

In patients with normal renal function, defined as CLcr> 60 ml/min, zoledronic acid 4 mg/100 ml solution for infusion must not be further diluted.
U bolesnika s normalnom funkcijom bubrega, koja se definira kao CLcr> 60 ml/min, zoledronatna kiselina 4 mg/100 ml otopina za infuziju ne smije se dodatno razrijediti.

Epoetin alfa HEXAL 1,000 IU/0.5 ml solution for injection in a pre-filled syringe Each syringe contains 0.5 ml of solution for injection.
Epoetin alfa HEXAL 1000 IU/0, 5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0, 5 ml otopine za injekciju.

In patients with moderate renal impairment(creatinine clearance 30- 49 ml/min) daily dose should be 10 mg 1 ml solution, equivalent to two pump actuations.
Kod bolesnika s umjerenim oštećenjem bubrega(klirens kreatinina 30-49 ml/min), dnevna doza bi trebala biti 10 mg 1 ml otopine, istovjetno dvama pokretanjima pumpice.

Packs containing 1, 5 or 10 pre-filled syringes with 0.5 mL solution or multipacks containing 10(2 packs of 5) pre-filled syringes with 0.5 mL solution.
Pakiranje sadrži 1, 5 ili 10 napunjenih štrcaljki s 0, 5 ml otopine ili višestruka pakiranja s 10(2 pakiranja od 5) napunjenih štrcaljki s 0, 5 ml otopine.

For paediatric dosing information for patients aged 2-12 years, see Summary of Product Characteristics for Humira 40 mg/0.8 ml solution for injection for paediatric use.
Za informacije o doziranju u pedijatrijskih bolesnika u dobi od 2-12 godina, vidjeti Sažetak opisa svojstava lijeka za Humira 40 mg/0, 8 ml otopinu za injekciju za pedijatrijsku uporabu.

Zarzio 30 MU/0.5 ml solution for injection or infusion in pre-filled syringe Zarzio 48 MU/0.5 ml solution for injection or infusion in pre-filled syringe.
Zarzio 30 MU/0, 5 ml otopina za injekciju ili infuziju u napunjenoj štrcaljki Zarzio 48 MU/0, 5 ml otopina za injekciju ili infuziju u napunjenoj štrcaljki.

In patients with normal renal function, defined as CLcr> 60 ml/min, zoledronic acid 4 mg/100 ml solution for infusion must not be further diluted.
U bolesnika s normalnom funkcijom bubrega, definiranom klirensom kreatinina većim od 60 ml/min, zoledronatna kiselina 4 mg/100 ml otopina za infuziju ne smije se dodatno razrjeđivati.

One pre-filled syringe with 0.3 ml solution for injection contains 2000 international units(IU) corresponding to 16.6 micrograms epoetin beta* recombinant human erythropoietin.
Jedna napunjena štrcaljka s 0, 3 ml otopine za injekciju sadrži 2000 internacionalnih jedinica(IU) što odgovara 16, 6 mikrograma epoetina beta* rekombinantnog ljudskog eritropoetina.

After reconstitution, there are 1,050 IU(77 micrograms) of follitropin alfa in 1.75 mL solution, that means there are 600 IU(44 micrograms) in each millilitre of solution..
Nakon pripreme za primjenu, u 1, 75 ml otopine nalazi se 1050 IU(77 mikrograma) folitropina alfa, što znači da se u svakom mililitru otopine nalazi 600 IU 44 mikrograma.

Ml solution in cartridge(type 1 glass) with a plunger(bromobutyl) and a rubber closure(bromobutyl/polyisoprene) contained in a pre-filled multidose disposable pen made of polypropylene.
Ml otopine u ulošku(staklo tipa 1) s klipom(brombutil) i gumenim zatvaračem(brombutil/poliizopren) nalazi se u jednokratnoj, višedoznoj napunjenoj brizgalici od polipropilena.

Pre-filled pens containing 0.3 ml, 0.4 ml, 0.5 ml, 0.6 ml, 0.7 ml, 0.8 ml, 0.9 ml or 1.0 ml solution for injection.
Napunjene brizgalice koje sadrže 0, 3 ml, 0, 4 ml, 0, 5 ml, 0, 6 ml, 0, 7 ml, 0, 8 ml, 0, 9 ml ili 1, 0 ml otopine za injekciju.

Nivestim 12 MU/ 0.2 ml solution for injection/infusion Nivestim 30 MU/ 0.5 ml solution for injection/infusion Nivestim 48 MU/ 0.5 ml solution for injection/infusion.
Nivestim 12 MU/ 0, 2 ml otopina za injekciju/infuziju Nivestim 30 MU/ 0, 5 ml otopina za injekciju/infuziju Nivestim 48 MU/ 0, 5 ml otopina za injekciju/infuziju.

Ml solution in a transparent, colourless, plastic(cycloolefinic copolymer) bottle closed with a fluorocarbon polymer coated bromobutyl rubber stopper and an aluminum cap with a flip-off component of polypropylene.
Ml otopine u prozirnoj, bezbojnoj, plastičnoj(cikloolefinski kopolimer) boci zatvorenoj s bromobutilnim gumenim čepom obloženim fluorougljičnim polimerom i aluminijskom kapicom s polipropilenskim„flip-off“ dijelom.